Chicago Woman is 'Poster Child' for Successful Breast Cancer Treatment
Betty Jones of Chicago is proud to be called a "poster girl" . . . especially when the term is used by her oncologist - Alexander Starr, M.D. - to describe her remarkable victory over breast cancer.
"'Betty,' he told me, 'You're my poster girl,'" she remembers with a smile.
Jones, who was diagnosed with advanced breast cancer in 2006, did a lot of research not only about her disease, but where she would get the best treatment. That led her to Ingalls.
"I could have gone to any hospital in Chicago if I wanted to, but I chose Ingalls," she recalls.
Jones is thrilled with her decision.
That's where she met Dr. Starr and the Ingalls cancer research team.
"This was my second bout with breast cancer," she explained. "I had a lumpectomy in my right breast the first time. That was in 2002."
Instead of an immediate mastectomy, Dr. Starr recommended Jones participate in a clinical trial involving the powerful, FDA-approved anticancer drug Sutent, in combination with Taxol. Sutent has successfully treated kidney and gastrointestinal stromal tumors, and Taxol has beenused for nearly a decade to treat breast cancer. In clinical trials, the two drugs together have shown promise in treating advanced breast cancer.
<"The combination of therapies literally melted away the tumor," Dr. Starr said. "Mrs. Jones had an excellent response to the clinical trial. When she had her mastectomy several months later, the tumor was gone."
Today, the busy wife, mother and grandmother enjoys dancing, walking, playing cards and staying active in her church.
Clinical Trials Offer Newest Cancer Treatments
Access to clinical trials is an opportunity to receive new, potentially more effective cancer therapies, including medications not yet approved by the Food and Drug Administration. What's more, Ingalls now offers Phase I clinical trials in addition to Phase II and III trials.
"Typically, Phase I and II studies are available only at academic medical centers," Dr. Starr explained.
Though the experimental treatment temporarily lightened her skin (Jones is African American), and caused an acne-like rash and painful sores in her mouth and on other parts of her body, Jones had done her homework beforehand and was able to stay the course.
"I did quite a bit of internet research. I read all the clinical trial literature; I prayed, talked to my doctors, my family, friends and the nurses within the health ministry at my church. And if it weren't for my husband, I don't know what I would have done. He was with me through it all."
For individuals who may not have a computer, Jones recommends using a friend's or visiting a local library.
"Ask a lot of questions," she added, "and rely on your faith to see you through. I'm grateful to Dr. Starr, to Ingalls, to my husband, who never missed an appointment with me, and to my family and friends for their support."
Ingalls is affiliated with more cancer research programs and clinical trials than any other cancer program in the South Suburbs. At any given time, Ingalls has more than 60 studies open for enrollment - covering most cancer sites in the body. Ingalls' Clinical Trials program is also a recipient of the prestigious "Pacesetter" award from the American College of Surgeons' Commission on Cancer.
For more information about cancer clinical trials at Ingalls, call the dedicated cancer research hotline at 708.915.HOPE (4673).


